Abstract
N1-ethyl-N11-[(cyclopropyl)methyl]-4,8,-diazaundecane (CPENSpm) is a polyamine analogue that represents a new class of antitumor agents that demonstrate phenotype-specific cytotoxic activity. However, the precise mechanism of its selective cytotoxic activity is not known. CPENSpm treatment results in the superinduction of the polyamine catabolic enzyme spermidine/spermineN1-acetyltransferase (SSAT) in sensitive cell types and has been demonstrated to induce programmed cell death (PCD). The catalysis of polyamines by the SSAT/polyamine oxidase (PAO) pathway produces H2O2as one product, suggesting that PCD produced by CPENSpm may be, in part, due to oxidative stress as a result of H2O2production. In the sensitive human nonsmall cell line H157, the coaddition of catalase significantly reduces high molecular weight (HMW) DNA (≥50 kb) and nuclear fragmentation. Important to note, specific inhibition of PAO byN,N′-bis(2,3-butadienyl)-1,4-butane-diamine results in a significant reduction of the formation of HMW DNA and nuclear fragmentation. In contrast, the coaddition of catalase or PAO inhibitor has no effect on reducing HMW DNA fragmentation induced byN1-ethyl-N11-[(cycloheptyl)methyl]-4,8,-diazaundecane, which does not induce SSAT and does not deplete intracellular polyamines. These results strongly suggest that H2O2production by PAO has a role in CPENSpm cytotoxicity in sensitive cells via PCD and demonstrate a potential basis for differential sensitivity to this promising new class of antineoplastic agents. Furthermore, the data suggest a general mechanism by which, under certain stimuli, cells can commit suicide through catabolism of the ubiquitous intracellular polyamines.
References
44
Referenced
212
10.1038/bjc.1972.33
10.1016/S0074-7696(08)62312-8
- G Majno, I Joris Am J Pathol 146, 3–15 (1995). / Am J Pathol by Majno G (1995)
10.1146/annurev.cb.07.110191.003311
10.1126/science.7878463
10.1073/pnas.93.6.2239
10.1006/taap.1994.1195
- A E Pegg Cancer Res 48, 759–774 (1988). / Cancer Res by Pegg A E (1988)
10.1146/annurev.pa.35.040195.000415
10.3109/07853899109148056
- C W Porter, R J Bernacki, J Miller, R J Bergeron Cancer Res 53, 581–586 (1993). / Cancer Res by Porter C W (1993)
10.1021/jm00401a019
10.1096/fasebj.7.8.8500690
- M A Desiderio, E Grassilli, E Bellesia, P Salomoni, C Franceschi Cell Growth Diff 6, 505–513 (1995). / Cell Growth Diff by Desiderio M A (1995)
10.1042/bj3110723
10.1016/S0021-9258(18)43849-5
- K E Tobias, C Kahana Cell Growth Diff 6, 1279–1285 (1995). / Cell Growth Diff by Tobias K E (1995)
10.1128/mcb.14.9.5741-5747.1994
10.1002/jcp.1041650320
10.1006/bbrc.1995.2679
- D E McCloskey, J Yang, P M Woster, N E Davidson, R A Casero Clin Cancer Res 2, 441–446 (1996). / Clin Cancer Res by McCloskey D E (1996)
- D E McCloskey, R A Casero, P M Woster, N E Davidson Cancer Res 55, 3233–3236 (1995). / Cancer Res by McCloskey D E (1995)
- D E McCloskey, L J Prestigiacomo, P M Woster, R A Casero, N E Davidson Proc Am Assoc Can Res 37, 400, (abstr.). (1996). / Proc Am Assoc Can Res by McCloskey D E (1996)
10.1007/BF00685735
10.1016/S0079-6123(08)61229-7
- P M Woster Polyamines: Regulation and Molecular InteractionR A Casero, ed R A Casero (Landes, Austin, TX), pp. 171–186 (1995). / Polyamines: Regulation and Molecular Interaction by Woster P M (1995)
- D G Hoyt, R J Mannix, J M Rusnak, B R Pitt, J S Lazo Am J Physiol 269, L171–L177 (1995). / Am J Physiol by Hoyt D G (1995)
10.1016/S0022-2836(75)80083-0
10.1016/0092-8674(93)80066-N
10.1177/30.9.6182188
- A Al-Mehdi, H Shuman, A B Fisher Lab Invest 70, 579–587 (1994). / Lab Invest by Al-Mehdi A (1994)
10.1126/science.270.5234.296
10.1042/bj2690329
10.1002/cyto.990160407
10.1007/BF00686190
- R A Casero, B Go, H W Theiss, J Smith, S B Baylin, G D Luk Cancer Res 47, 3964–3967 (1987). / Cancer Res by Casero R A (1987)
10.1042/bj2910131
10.1073/pnas.86.10.3654
10.1073/pnas.87.11.4340
- R E Parchment, G B Pierce Cancer Res 49, 6680–6686 (1989). / Cancer Res by Parchment R E (1989)
- R E Parchment Int J Dev Biol 37, 75–83 (1993). / Int J Dev Biol by Parchment R E (1993)
-
G Packhamn, R A Ashmun, J L Cleveland J Immunol 156, 2792–2800 (1996).
(
10.4049/jimmunol.156.8.2792
) / J Immunol by Packhamn G (1996) - R A Casero, A R Mank, L Xiao, J Smith, R J Bergeron, P Celano Cancer Res 52, 5359–5363 (1992). / Cancer Res by Casero R A (1992)
- N W Shappell, J T Miller, R J Bergeron, C W Porter Anticancer Res 12, 1083–1090 (1992). / Anticancer Res by Shappell N W (1992)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 10:42 a.m.) |
Deposited | 2 years, 4 months ago (April 22, 2023, 8:33 a.m.) |
Indexed | 3 weeks, 1 day ago (Aug. 7, 2025, 4:41 p.m.) |
Issued | 27 years, 10 months ago (Oct. 14, 1997) |
Published | 27 years, 10 months ago (Oct. 14, 1997) |
Published Online | 27 years, 10 months ago (Oct. 14, 1997) |
Published Print | 27 years, 10 months ago (Oct. 14, 1997) |
@article{Ha_1997, title={The role of polyamine catabolism in polyamine analogue-induced programmed cell death}, volume={94}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.94.21.11557}, DOI={10.1073/pnas.94.21.11557}, number={21}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Ha, Hyo Chol and Woster, Patrick M. and Yager, James D. and Casero, Robert A.}, year={1997}, month=oct, pages={11557–11562} }